English

RESPONSE ONCOLOGY INC

EDGAR

Quarterly report (10-Q) · filed 2002-06-25

31 filing records in this dataset, filed from 1995-05-12 to 2002-06-25. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

22.8 million USD

2002-03-31 · USD

Exact inputs and evidence

Revenue: 22790000 USD Source

Net margin

-4.01%

2002-03-31 · %

Exact inputs and evidence

Net Income: -915000 USD Source
Revenue: 22790000 USD Source

Operating cash flow

2.44 million USD

2002-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 2437000 USD Source

Free cash flow

2.42 million USD

2002-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 2437000 USD Source
Capital Expenditure: 13000 USD Source

Cash and cash equivalents: 9.01 million USD 2002-03-31 Source
Exact value

9008000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

109 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Revenue: 30922000 USD · 2001-04-01 – 2001-06-30 Source
Revenue: 29542000 USD · 2001-07-01 – 2001-09-30 Source
Revenue: 118085000 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 92015000 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 22790000 USD · 2002-01-01 – 2002-03-31 Source

Net income

-51.1 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Net income: -872000 USD · 2001-04-01 – 2001-06-30 Source
Net income: -707000 USD · 2001-07-01 – 2001-09-30 Source
Net income: -51393000 USD · 2001-01-01 – 2001-12-31 Source
Net income: -2799000 USD · 2001-01-01 – 2001-09-30 Source
Net income: -915000 USD · 2002-01-01 – 2002-03-31 Source

Operating cash flow

7.84 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Operating cash flow: 7438000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: 3698000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: 6491000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: 7438000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: 9099000 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: 6491000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: 2437000 USD · 2002-01-01 – 2002-03-31 Source

Capital expenditure

96 thousand USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Capital expenditure: 59000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 42000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 107000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 59000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 125000 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 107000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 13000 USD · 2002-01-01 – 2002-03-31 Source

Free cash flow

7.74 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Operating cash flow: 7438000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: 3698000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: 6491000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: 7438000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: 9099000 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: 6491000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: 2437000 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 59000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 42000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 107000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 59000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 125000 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 107000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 13000 USD · 2002-01-01 – 2002-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-06-25.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2001-12-31
operating income: No compatible figures in this window
Net income: 9 of 11 periods available· newest 2001-12-31
Operating cash flow: 9 of 11 periods available· newest 2001-12-31
Capital expenditure: 9 of 11 periods available· newest 2001-12-31
Total assets: 8 of 11 periods available· newest 2001-12-31
liabilities: No compatible figures in this window
Current assets: 8 of 11 periods available· newest 2001-12-31
Current liabilities: 8 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-9.7%

Prior period

USD 130.83 million

2000-01-01 – 2000-12-31
Current period

USD 118.09 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

118085000 − 130833000 = -12748000 USD

130833000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
118085000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Year-over-year change in Revenue: -12748000 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 118085000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#5708 Input fundies:Revenue: 130833000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#5708
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 36.97 million

Prior period

−USD 14.42 million

2000-01-01 – 2000-12-31
Current period

−USD 51.39 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-51393000 − -14419000 = -36974000 USD

-14419000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-51393000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Year-over-year change in Net income: -36974000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -51393000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7166 Input fundies:NetIncome: -14419000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7166
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+77.7%

Prior period

USD 5.12 million

2000-01-01 – 2000-12-31
Current period

USD 9.1 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

9099000 − 5121000 = 3978000 USD

5121000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
9099000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Year-over-year change in Operating cash flow: 3978000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 9099000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523 Input fundies:OperatingCashFlow: 5121000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-80.6%

Prior period

USD 645,000

2000-01-01 – 2000-12-31
Current period

USD 125,000

2001-01-01 – 2001-12-31

Exact inputs and evidence

125000 − 645000 = -520000 USD

645000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
125000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Year-over-year change in Capital expenditure: -520000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 125000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555 Input fundies:CapitalExpenditure: 645000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 118.09 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 51.39 million −44% of revenue

Cash

Operating cash flow USD 9.1 million 7.7% of revenue
Capital expenditure USD 125,000 0.1% of revenue
Free cash flow Derived USD 8.97 million 7.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 Not shown: operating income or net income is not reported.
1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Not shown: operating income or net income is not reported.
2000 Not shown: operating income or net income is not reported.
2001 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1993-01-01 – 1993-12-31	37696594	Unavailable	Unavailable	Unavailable	699533	-6179047 Derived	Source 1993-01-01 – 1993-12-31: 37696594 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: 699533 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: -5065470 USD Inspect Operating Cash Flow Open source 1993-01-01 – 1993-12-31: 1113577 USD Inspect Capital Expenditure Open source
1994 1994-01-01 – 1994-12-31	38251000	Unavailable	Unavailable	Unavailable	-2346000	2498000 Derived	Source 1994-01-01 – 1994-12-31: 38251000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -2346000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: 3084000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 586000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	44298000	Unavailable	Unavailable	Unavailable	2314000	761000 Derived	Source 1995-01-01 – 1995-12-31: 44298000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: 2314000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: 2091000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 1330000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	67353000	Unavailable	Unavailable	Unavailable	910000	-4757000 Derived	Source 1996-01-01 – 1996-12-31: 67353000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: 910000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -3723000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 1034000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	101920000	Unavailable	Unavailable	Unavailable	4202000	5595000 Derived	Source 1997-01-01 – 1997-12-31: 101920000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: 4202000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 6573000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 978000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	128246000	Unavailable	Unavailable	Unavailable	-17448000	1079000 Derived	Source 1998-01-01 – 1998-12-31: 128246000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -17448000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 2781000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1702000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	135567000	Unavailable	Unavailable	Unavailable	-1693000	12054000 Derived	Source 1999-01-01 – 1999-12-31: 135567000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -1693000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 12795000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 741000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	130833000	Unavailable	Unavailable	Unavailable	-14419000	4476000 Derived	Source 2000-01-01 – 2000-12-31: 130833000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -14419000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 5121000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 645000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	118085000	Unavailable	Unavailable	Unavailable	-51393000	8974000 Derived	Source 2001-01-01 – 2001-12-31: 118085000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -51393000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 9099000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 125000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 118.1M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Revenue	37696594	Revenue: 37696594 Open source
19941994-12-31	Revenue	38251000	Revenue: 38251000 Open source
19951995-12-31	Revenue	44298000	Revenue: 44298000 Open source
19961996-12-31	Revenue	67353000	Revenue: 67353000 Open source
19971997-12-31	Revenue	101920000	Revenue: 101920000 Open source
19981998-12-31	Revenue	128246000	Revenue: 128246000 Open source
19991999-12-31	Revenue	135567000	Revenue: 135567000 Open source
20002000-12-31	Revenue	130833000	Revenue: 130833000 Open source
20012001-12-31	Revenue	118085000	Revenue: 118085000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-9.7% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Year over year	No prior comparable period	Revenue: 37696594 Open source
19941994-12-31	Year over year	1.5%	Revenue: 38251000 Open source Revenue: 37696594 Open source
19951995-12-31	Year over year	15.8%	Revenue: 44298000 Open source Revenue: 38251000 Open source
19961996-12-31	Year over year	52%	Revenue: 67353000 Open source Revenue: 44298000 Open source
19971997-12-31	Year over year	51.3%	Revenue: 101920000 Open source Revenue: 67353000 Open source
19981998-12-31	Year over year	25.8%	Revenue: 128246000 Open source Revenue: 101920000 Open source
19991999-12-31	Year over year	5.7%	Revenue: 135567000 Open source Revenue: 128246000 Open source
20002000-12-31	Year over year	-3.5%	Revenue: 130833000 Open source Revenue: 135567000 Open source
20012001-12-31	Year over year	-9.7%	Revenue: 118085000 Open source Revenue: 130833000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -43.5% 2001

Free cash flow margin 7.6% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Operating margin	Not reported	Revenue: 37696594 Open source
1994-12-31	Operating margin	Not reported	Revenue: 38251000 Open source
1995-12-31	Operating margin	Not reported	Revenue: 44298000 Open source
1996-12-31	Operating margin	Not reported	Revenue: 67353000 Open source
1997-12-31	Operating margin	Not reported	Revenue: 101920000 Open source
1998-12-31	Operating margin	Not reported	Revenue: 128246000 Open source
1999-12-31	Operating margin	Not reported	Revenue: 135567000 Open source
2000-12-31	Operating margin	Not reported	Revenue: 130833000 Open source
2001-12-31	Operating margin	Not reported	Revenue: 118085000 Open source
19931993-12-31	Net margin	1.9%	Net Income: 699533 Open source Revenue: 37696594 Open source
19941994-12-31	Net margin	-6.1%	Net Income: -2346000 Open source Revenue: 38251000 Open source
19951995-12-31	Net margin	5.2%	Net Income: 2314000 Open source Revenue: 44298000 Open source
19961996-12-31	Net margin	1.4%	Net Income: 910000 Open source Revenue: 67353000 Open source
19971997-12-31	Net margin	4.1%	Net Income: 4202000 Open source Revenue: 101920000 Open source
19981998-12-31	Net margin	-13.6%	Net Income: -17448000 Open source Revenue: 128246000 Open source
19991999-12-31	Net margin	-1.2%	Net Income: -1693000 Open source Revenue: 135567000 Open source
20002000-12-31	Net margin	-11%	Net Income: -14419000 Open source Revenue: 130833000 Open source
20012001-12-31	Net margin	-43.5%	Net Income: -51393000 Open source Revenue: 118085000 Open source
19931993-12-31	Free cash flow margin	-16.4%	Revenue: 37696594 Open source Operating Cash Flow: -5065470 Open source Capital Expenditure: 1113577 Open source
19941994-12-31	Free cash flow margin	6.5%	Revenue: 38251000 Open source Operating Cash Flow: 3084000 Open source Capital Expenditure: 586000 Open source
19951995-12-31	Free cash flow margin	1.7%	Revenue: 44298000 Open source Operating Cash Flow: 2091000 Open source Capital Expenditure: 1330000 Open source
19961996-12-31	Free cash flow margin	-7.1%	Revenue: 67353000 Open source Operating Cash Flow: -3723000 Open source Capital Expenditure: 1034000 Open source
19971997-12-31	Free cash flow margin	5.5%	Revenue: 101920000 Open source Operating Cash Flow: 6573000 Open source Capital Expenditure: 978000 Open source
19981998-12-31	Free cash flow margin	0.8%	Revenue: 128246000 Open source Operating Cash Flow: 2781000 Open source Capital Expenditure: 1702000 Open source
19991999-12-31	Free cash flow margin	8.9%	Revenue: 135567000 Open source Operating Cash Flow: 12795000 Open source Capital Expenditure: 741000 Open source
20002000-12-31	Free cash flow margin	3.4%	Revenue: 130833000 Open source Operating Cash Flow: 5121000 Open source Capital Expenditure: 645000 Open source
20012001-12-31	Free cash flow margin	7.6%	Revenue: 118085000 Open source Operating Cash Flow: 9099000 Open source Capital Expenditure: 125000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 9.1M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Operating cash flow	-5065470	Operating Cash Flow: -5065470 Open source
19941994-12-31	Operating cash flow	3084000	Operating Cash Flow: 3084000 Open source
19951995-12-31	Operating cash flow	2091000	Operating Cash Flow: 2091000 Open source
19961996-12-31	Operating cash flow	-3723000	Operating Cash Flow: -3723000 Open source
19971997-12-31	Operating cash flow	6573000	Operating Cash Flow: 6573000 Open source
19981998-12-31	Operating cash flow	2781000	Operating Cash Flow: 2781000 Open source
19991999-12-31	Operating cash flow	12795000	Operating Cash Flow: 12795000 Open source
20002000-12-31	Operating cash flow	5121000	Operating Cash Flow: 5121000 Open source
20012001-12-31	Operating cash flow	9099000	Operating Cash Flow: 9099000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 9M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Free cash flow	-6179047	Operating Cash Flow: -5065470 Open source Capital Expenditure: 1113577 Open source
19941994-12-31	Free cash flow	2498000	Operating Cash Flow: 3084000 Open source Capital Expenditure: 586000 Open source
19951995-12-31	Free cash flow	761000	Operating Cash Flow: 2091000 Open source Capital Expenditure: 1330000 Open source
19961996-12-31	Free cash flow	-4757000	Operating Cash Flow: -3723000 Open source Capital Expenditure: 1034000 Open source
19971997-12-31	Free cash flow	5595000	Operating Cash Flow: 6573000 Open source Capital Expenditure: 978000 Open source
19981998-12-31	Free cash flow	1079000	Operating Cash Flow: 2781000 Open source Capital Expenditure: 1702000 Open source
19991999-12-31	Free cash flow	12054000	Operating Cash Flow: 12795000 Open source Capital Expenditure: 741000 Open source
20002000-12-31	Free cash flow	4476000	Operating Cash Flow: 5121000 Open source Capital Expenditure: 645000 Open source
20012001-12-31	Free cash flow	8974000	Operating Cash Flow: 9099000 Open source Capital Expenditure: 125000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Liabilities / assets	Not reported	No source recorded
1994-12-31	Liabilities / assets	Not reported	Total Assets: 21036715 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 24765000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 142950000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 149075000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 126753000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 119645000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 92413000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 28902000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

12.18× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Current assets / current liabilities	Not reported	No source recorded
19941994-12-31	Current assets / current liabilities	3.73×	Current Assets: 16785831 Open source Current Liabilities: 4500898 Open source
19951995-12-31	Current assets / current liabilities	4.23×	Current Assets: 20637000 Open source Current Liabilities: 4884000 Open source
19961996-12-31	Current assets / current liabilities	1.86×	Current Assets: 31718000 Open source Current Liabilities: 17052000 Open source
19971997-12-31	Current assets / current liabilities	1.81×	Current Assets: 41149000 Open source Current Liabilities: 22703000 Open source
19981998-12-31	Current assets / current liabilities	1.46×	Current Assets: 52239000 Open source Current Liabilities: 35815000 Open source
19991999-12-31	Current assets / current liabilities	1.93×	Current Assets: 48463000 Open source Current Liabilities: 25117000 Open source
20002000-12-31	Current assets / current liabilities	0.82×	Current Assets: 44316000 Open source Current Liabilities: 54032000 Open source
20012001-12-31	Current assets / current liabilities	12.18×	Current Assets: 28155000 Open source Current Liabilities: 2311000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1993-01-01 – 1993-12-31	USD 699,533 Exact value Exact value: 699533 USD 1993-01-01 – 1993-12-31: 699533 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 1993-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: 699533 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: 699533 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-96-001447.txt#1295 The citation records this snapshot. The page link may show a newer release later.	−USD 5.07 million Exact value Exact value: -5065470 USD 1993-01-01 – 1993-12-31: -5065470 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 1993-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: -5065470 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5065470 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-96-001447.txt#1310 The citation records this snapshot. The page link may show a newer release later.	USD 1.11 million Exact value Exact value: 1113577 USD 1993-01-01 – 1993-12-31: 1113577 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 1993-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 1113577 USD Concept: fundies:CapitalExpenditure Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1113577 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-96-001447.txt#1312 The citation records this snapshot. The page link may show a newer release later.	−USD 6.18 million Calculation and evidence -5065470 − 1113577 USD Exact free cash flow: -6179047 USD 1993-01-01 – 1993-12-31: -5065470 USD · Inspect Operating Cash Flow · Source 1993-01-01 – 1993-12-31: 1113577 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 1993-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: -6179047 USD Concept: free-cash-flow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5065470 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-96-001447.txt#1310 Input fundies:CapitalExpenditure: 1113577 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-96-001447.txt#1312 The citation records this snapshot. The page link may show a newer release later.
1994 1994-01-01 – 1994-12-31	−USD 2.35 million Exact value Exact value: -2346000 USD 1994-01-01 – 1994-12-31: -2346000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 1994-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: -2346000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2346000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-97-005598.txt#1721 The citation records this snapshot. The page link may show a newer release later.	USD 3.08 million Exact value Exact value: 3084000 USD 1994-01-01 – 1994-12-31: 3084000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 1994-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: 3084000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3084000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-97-005598.txt#1736 The citation records this snapshot. The page link may show a newer release later.	USD 586,000 Exact value Exact value: 586000 USD 1994-01-01 – 1994-12-31: 586000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 1994-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 586000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 586000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-97-005598.txt#1739 The citation records this snapshot. The page link may show a newer release later.	USD 2.5 million Calculation and evidence 3084000 − 586000 USD Exact free cash flow: 2498000 USD 1994-01-01 – 1994-12-31: 3084000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 586000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 1994-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: 2498000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3084000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-97-005598.txt#1736 Input fundies:CapitalExpenditure: 586000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-97-005598.txt#1739 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	USD 2.31 million Exact value Exact value: 2314000 USD 1995-01-01 – 1995-12-31: 2314000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 1995-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: 2314000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2314000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-98-003982.txt#1731 The citation records this snapshot. The page link may show a newer release later.	USD 2.09 million Exact value Exact value: 2091000 USD 1995-01-01 – 1995-12-31: 2091000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 1995-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: 2091000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2091000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-98-003982.txt#1746 The citation records this snapshot. The page link may show a newer release later.	USD 1.33 million Exact value Exact value: 1330000 USD 1995-01-01 – 1995-12-31: 1330000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 1995-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 1330000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1330000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-98-003982.txt#1750 The citation records this snapshot. The page link may show a newer release later.	USD 761,000 Calculation and evidence 2091000 − 1330000 USD Exact free cash flow: 761000 USD 1995-01-01 – 1995-12-31: 2091000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 1330000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 1995-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: 761000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2091000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-98-003982.txt#1746 Input fundies:CapitalExpenditure: 1330000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-98-003982.txt#1750 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	USD 910,000 Exact value Exact value: 910000 USD 1996-01-01 – 1996-12-31: 910000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 1996-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: 910000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: 910000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-99-003885.txt#1841 The citation records this snapshot. The page link may show a newer release later.	−USD 3.72 million Exact value Exact value: -3723000 USD 1996-01-01 – 1996-12-31: -3723000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 1996-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: -3723000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3723000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-99-003885.txt#1858 The citation records this snapshot. The page link may show a newer release later.	USD 1.03 million Exact value Exact value: 1034000 USD 1996-01-01 – 1996-12-31: 1034000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 1996-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 1034000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1034000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-99-003885.txt#1861 The citation records this snapshot. The page link may show a newer release later.	−USD 4.76 million Calculation and evidence -3723000 − 1034000 USD Exact free cash flow: -4757000 USD 1996-01-01 – 1996-12-31: -3723000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 1034000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 1996-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: -4757000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3723000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-99-003885.txt#1858 Input fundies:CapitalExpenditure: 1034000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-99-003885.txt#1861 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	USD 4.2 million Exact value Exact value: 4202000 USD 1997-01-01 – 1997-12-31: 4202000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 1997-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: 4202000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4202000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-00-004312.txt#1812 The citation records this snapshot. The page link may show a newer release later.	USD 6.57 million Exact value Exact value: 6573000 USD 1997-01-01 – 1997-12-31: 6573000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 1997-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: 6573000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6573000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-00-004312.txt#1829 The citation records this snapshot. The page link may show a newer release later.	USD 978,000 Exact value Exact value: 978000 USD 1997-01-01 – 1997-12-31: 978000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 1997-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 978000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 978000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-00-004312.txt#1833 The citation records this snapshot. The page link may show a newer release later.	USD 5.6 million Calculation and evidence 6573000 − 978000 USD Exact free cash flow: 5595000 USD 1997-01-01 – 1997-12-31: 6573000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 978000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 1997-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: 5595000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6573000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-00-004312.txt#1829 Input fundies:CapitalExpenditure: 978000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-00-004312.txt#1833 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 17.45 million Exact value Exact value: -17448000 USD 1998-01-01 – 1998-12-31: -17448000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 1998-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: -17448000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17448000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-01-500861.txt#2239 The citation records this snapshot. The page link may show a newer release later.	USD 2.78 million Exact value Exact value: 2781000 USD 1998-01-01 – 1998-12-31: 2781000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 1998-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: 2781000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2781000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-01-500861.txt#2258 The citation records this snapshot. The page link may show a newer release later.	USD 1.7 million Exact value Exact value: 1702000 USD 1998-01-01 – 1998-12-31: 1702000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 1998-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 1702000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1702000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-01-500861.txt#2262 The citation records this snapshot. The page link may show a newer release later.	USD 1.08 million Calculation and evidence 2781000 − 1702000 USD Exact free cash flow: 1079000 USD 1998-01-01 – 1998-12-31: 2781000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1702000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 1998-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: 1079000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2781000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-01-500861.txt#2258 Input fundies:CapitalExpenditure: 1702000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-01-500861.txt#2262 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 1.69 million Exact value Exact value: -1693000 USD 1999-01-01 – 1999-12-31: -1693000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 1999-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: -1693000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1693000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7166 The citation records this snapshot. The page link may show a newer release later.	USD 12.8 million Exact value Exact value: 12795000 USD 1999-01-01 – 1999-12-31: 12795000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 1999-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: 12795000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 12795000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523 The citation records this snapshot. The page link may show a newer release later.	USD 741,000 Exact value Exact value: 741000 USD 1999-01-01 – 1999-12-31: 741000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 1999-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 741000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 741000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555 The citation records this snapshot. The page link may show a newer release later.	USD 12.05 million Calculation and evidence 12795000 − 741000 USD Exact free cash flow: 12054000 USD 1999-01-01 – 1999-12-31: 12795000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 741000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 1999-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: 12054000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 12795000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523 Input fundies:CapitalExpenditure: 741000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 14.42 million Exact value Exact value: -14419000 USD 2000-01-01 – 2000-12-31: -14419000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 2000-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: -14419000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14419000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7166 The citation records this snapshot. The page link may show a newer release later.	USD 5.12 million Exact value Exact value: 5121000 USD 2000-01-01 – 2000-12-31: 5121000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 2000-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: 5121000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5121000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523 The citation records this snapshot. The page link may show a newer release later.	USD 645,000 Exact value Exact value: 645000 USD 2000-01-01 – 2000-12-31: 645000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 2000-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 645000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 645000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555 The citation records this snapshot. The page link may show a newer release later.	USD 4.48 million Calculation and evidence 5121000 − 645000 USD Exact free cash flow: 4476000 USD 2000-01-01 – 2000-12-31: 5121000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 645000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 2000-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: 4476000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5121000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523 Input fundies:CapitalExpenditure: 645000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 51.39 million Exact value Exact value: -51393000 USD 2001-01-01 – 2001-12-31: -51393000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Net Income: -51393000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51393000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7166 The citation records this snapshot. The page link may show a newer release later.	USD 9.1 million Exact value Exact value: 9099000 USD 2001-01-01 – 2001-12-31: 9099000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Operating Cash Flow: 9099000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9099000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523 The citation records this snapshot. The page link may show a newer release later.	USD 125,000 Exact value Exact value: 125000 USD 2001-01-01 – 2001-12-31: 125000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Capital Expenditure: 125000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 125000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555 The citation records this snapshot. The page link may show a newer release later.	USD 8.97 million Calculation and evidence 9099000 − 125000 USD Exact free cash flow: 8974000 USD 2001-01-01 – 2001-12-31: 9099000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 125000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE ONCOLOGY INC · 2001-12-31 RESPONSE ONCOLOGY INC (edgar:763098) Free cash flow: 8974000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T05:16:56Z Snapshot: 5524bf69b400d96abb7c2258dcc05b825947eee4f59fe594166e3c6b0357252e Dimensions: Consolidated View: https://fundies.io/companies/edgar/763098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9099000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7523 Input fundies:CapitalExpenditure: 125000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/763098/0000950144-02-006511.txt#7555 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000763098, 763098, edgar:763098

Also known as RESPONSE TECHNOLOGIES INC

RESPONSE ONCOLOGY INC

Latest quarter

Revenue

Net margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation